KLP Kapitalforvaltning AS Acquires New Shares in The Cooper Companies, Inc. (NASDAQ:COO)

KLP Kapitalforvaltning AS acquired a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 66,200 shares of the medical device company's stock, valued at approximately $6,086,000.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Empowered Funds LLC lifted its position in shares of Cooper Companies by 8.7% in the 3rd quarter. Empowered Funds LLC now owns 3,086 shares of the medical device company's stock worth $341,000 after purchasing an additional 248 shares during the period. Pathstone Holdings LLC lifted its holdings in Cooper Companies by 3.8% in the third quarter. Pathstone Holdings LLC now owns 22,109 shares of the medical device company's stock valued at $2,440,000 after buying an additional 800 shares during the period. Eagle Asset Management Inc. bought a new stake in Cooper Companies during the third quarter valued at $2,619,000. Raymond James Trust N.A. grew its holdings in Cooper Companies by 22.3% during the 3rd quarter. Raymond James Trust N.A. now owns 3,140 shares of the medical device company's stock worth $346,000 after acquiring an additional 573 shares during the period. Finally, Cerity Partners LLC raised its position in shares of Cooper Companies by 56.4% in the 3rd quarter. Cerity Partners LLC now owns 19,179 shares of the medical device company's stock worth $2,116,000 after acquiring an additional 6,916 shares in the last quarter. 24.39% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

COO has been the topic of several research analyst reports. Needham & Company LLC restated a "hold" rating on shares of Cooper Companies in a research report on Friday, March 7th. Stifel Nicolaus cut their price target on Cooper Companies from $115.00 to $105.00 and set a "buy" rating on the stock in a report on Friday, March 7th. Wells Fargo & Company lifted their price objective on shares of Cooper Companies from $115.00 to $118.00 and gave the company an "overweight" rating in a research note on Friday, December 6th. Piper Sandler reissued an "overweight" rating and set a $115.00 price objective (down previously from $120.00) on shares of Cooper Companies in a research report on Friday, March 7th. Finally, Robert W. Baird decreased their target price on Cooper Companies from $117.00 to $107.00 and set an "outperform" rating for the company in a research report on Friday, March 7th. Four analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $110.25.

Remove Ads

Cooper Companies Stock Performance

Shares of NASDAQ:COO traded down $1.21 during mid-day trading on Friday, reaching $83.77. The company had a trading volume of 1,736,366 shares, compared to its average volume of 1,343,868. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32. The company's 50-day moving average price is $89.33 and its 200-day moving average price is $97.29. The Cooper Companies, Inc. has a one year low of $77.05 and a one year high of $112.38. The firm has a market cap of $16.75 billion, a price-to-earnings ratio of 42.96, a PEG ratio of 2.25 and a beta of 1.02.

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its quarterly earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share for the quarter, hitting the consensus estimate of $0.92. The company had revenue of $964.70 million during the quarter, compared to the consensus estimate of $981.25 million. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. As a group, equities research analysts anticipate that The Cooper Companies, Inc. will post 3.98 EPS for the current fiscal year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.